According to the report, the Global Breast Imaging
Technologies Market accounted for $2.54 billion in 2015 and is
expected to reach $4.50 billion by 2022, registering a CAGR of 8.4% during
the study period.
Increasing
prevalence of breast cancer, rapid technological advancements, and increase in
awareness regarding breast cancer have boosted the growth of the global breast
imaging technologies market. However, high cost of breast cancer detection
imaging modalities and stringent regulatory approval procedure hamper the
market growth. On the contrary, untapped markets in the emerging countries are
expected to create lucrative opportunities in the near future.
Download Sample Report @ https://www.alliedmarketresearch.com/request-sample/5056
Global
breast imaging technologies market is divided on the basis of product type and
region. Based on product type, the market is segmented into ionizing breast imaging
technologies and non-ionizing breast imaging technologies. The ionizing breast
imaging technologies segment held the largest share in 2015, owing to its
ability to identify breast imaging tools facilitate faster interpretation of
breast tissues and create less false positive results as compared to MRI.
However, the non-ionizing breast imaging technologies segment is expected to
manifest the fastest CAGR through 2022, owing to introduction of better imaging
models including automated whole breast ultrasound system (ABUS). Moreover,
these techniques use infrared radiations, which have a better chance of
reducing the risk of the development of radiation-induced cancer.
The
ionizing breast imaging technologies segment is further divided into analog
mammography, full-field digital mammography (FFDM), 3D breast tomosynthesis,
positron emission tomography/computed tomography (PET/CT), molecular breast
imaging/breast-specific gamma imaging (MBI/BSGI), cone beam computed tomography
(CBCT), and positron emission mammography (PEM). The full-field digital
mammography systems segment held the largest share in 2015, as it is time
efficient and needless radiation dose than other technologies. Moreover,
radiologists can adjust the brightness of the breast image, making it easier to
observe the breast tissues. However, the 3D breast tomosynthesis segment is
estimated to register the fastest CAGR during the forecast period, as this method
offers easy detection of breast cancer in women with dense breast tissues.
Based
on geography, the market is divided into North America, Europe, Asia-Pacific,
and LAMEA. The market in North America held the largest share in 2015 and is
projected to maintain its dominance throughout the forecast period, owing to
increase in the prevalence of breast cancer and surge in awareness regarding
cancer among patients. However, Asia-Pacific region is expected to register a
CAGR of 9.5% during the forecast period.
The
report includes analysis of the major market players such as FUJIFILM Holdings
Corporation, Dilon Technologies, Inc., General Electric Company, Gamma Medica,
Inc., Koning Corporation, Hologic, Inc., Siemens AG, Koninklijke Philips N.V.,
Sonocin, Inc., and Toshiba Corporation.
Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/5056
No comments:
Post a Comment